Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 23, 2004
- Accepted June 8, 2004
- Published online October 13, 2004.
Article Versions
- Earlier version (June 9, 2004 - 13:22).
- You are viewing the most recent version of this article.
Copyright & Usage
The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Atsushi Fukunari,
- Ken Okamoto,
- Takeshi Nishino,
- Bryan T. Eger,
- Emil F. Pai,
- Miho Kamezawa,
- Ichimaro Yamada and
- Norihisa Kato
- Pharmaceutical Research Unit, Mitsubishi Pharma Corporation, Yokohama, Japan (A.F., M.K., I.Y.); Department of Biochemistry and Molecular Biology, Nippon Medical School, Tokyo, Japan (K.O., T.N.); Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada (B.T.E.); Departments of Biochemistry, Medical Biophysics, and Medical Genetics and Microbiology, University of Toronto and Division of Molecular and Structural Biology, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Ontario, Canada (E.F.P.); and Department of Bioresource Science and Technology, Hiroshima University, Hiroshima, Japan (N.K.)
- Address correspondence to:
Atsushi Fukunari, Discovery Technology Laboratory, Pharmaceuticals Research Unit, Mitsubishi Pharma Corporation, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. E-mail: fukunari.atsushi{at}mb.m-pharma.co.jp
Statistics from Altmetric.com
Article usage
In this issue
Y-700 [1-[3-Cyano-4-(2,2-dimethylpropoxy)phenyl]-1H-pyrazole-4-carboxylic Acid]: A Potent Xanthine Oxidoreductase Inhibitor with Hepatic Excretion
